经尿道等离子膀胱肿瘤剜除术治疗膀胱平滑肌瘤的临床分析  

Clinical analysis of transurethral plasma bladder tumor enucleation for the treatment of bladder leiomyoma

作　　者：李勉洲 路建磊 王超 LI Mianzhou;LU Jianlei;WANG Chao(Department of Urology,Jining First People's Hospital,Jining,Shandong,272100,China)

机构地区：[1]济宁市第一人民院泌尿外科,山东济宁272100

出　　处：《临床泌尿外科杂志》2024年第3期203-205,共3页Journal of Clinical Urology

基　　金：济宁医学院实践教学教育科学研究项目(No:JYSJ2020A20)。

摘　　要：目的:探讨经尿道等离子膀胱肿瘤剜除术治疗膀胱平滑肌瘤的临床疗效。方法:回顾性分析2012年12月—2022年12月济宁市第一人民院治疗的6例膀胱平滑肌瘤患者的临床资料,所有患者均采用经尿道等离子膀胱肿瘤剜除术完整剜除肿瘤,再将组织切成小块冲出。结果:6例患者平均手术时间30 min,术后无出血、穿孔、感染等并发症,术后病理诊断为膀胱平滑肌瘤,均顺利康复出院。术后随访1~3年未见复发。结论:经尿道等离子膀胱肿瘤剜除术治疗膀胱平滑肌瘤创伤小、恢复快,是治疗膀胱良性肿瘤安全可靠的手术方式。Objective: To investigate the clinical effect of transurethral plasma enucleation of bladder tumor in the treatment of bladder leiomyoma. Methods: The clinical data of 6 patients with bladder leiomyoma treated in Jining First People's Hospital from December 2012 to December 2022 were retrospectively analyzed. All patients underwent transurethral plasma enucleation of bladder tumor, and then the tissue was cut into small pieces and washed out. Results: The average operation time of the 6 patients was about 30 minutes. There were no adverse complications such as bleeding, perforation, infection and so on. The patients were followed up for 1-3 years and no recurrence was found. Conclusion: Transurethral plasma enucleation of bladder leiomyoma is a safe and reliable surgical method for the treatment of bladder benign tumors.

关 键 词：膀胱肿瘤 膀胱平滑肌瘤 肿瘤剜除术 

分 类 号：R737.14[医药卫生—肿瘤]